These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31341412)

  • 1. Locus 5p13.1 may be associated with the selection of cancer-related HBV core promoter mutations.
    Chen QY; Hu YL; Wang XY; Harrison TJ; Wang C; Hu LP; Yang QL; Ren CC; Jia HH; Fang AZ
    Int J Med Sci; 2019; 16(7):990-997. PubMed ID: 31341412
    [No Abstract]   [Full Text] [Related]  

  • 2. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
    Yang Z; Zhuang L; Lu Y; Xu Q; Tang B; Chen X
    Oncotarget; 2016 Mar; 7(11):12525-36. PubMed ID: 26848866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes.
    Song XM; Li QL; Guo F; Peng H; Guo JJ
    Ann Hepatol; 2018 Oct; 17(6):940-947. PubMed ID: 30600290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
    Ma XY; Han T; Pei YZ; Zhao ZG; Gao YT; Li Y; Jing L
    Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):644-8. PubMed ID: 23207226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
    Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH
    World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B Virus Core Promoter Double Mutations (A1762T, G1764A) Are Associated with Lower Levels of Serum Dihydrolipoyl Dehydrogenase.
    Jiang ZH; Chen QY; Harrison TJ; Li GJ; Wang XY; Li H; Hu LP; Li KW; Yang QL; Tan C; Fang ZL
    Intervirology; 2016; 59(1):1-7. PubMed ID: 27303803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
    Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
    World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
    Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
    J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
    Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ;
    J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.
    Ducancelle A; Pivert A; Bertrais S; Boursier J; Balan V; Veillon P; le Guillou-Guillemette H; Thibault V; Castelain S; Roquebert B; Coste-Burel M; Mackiewicz V; Schvoerer E; Larrat S; Maylin S; Alain S; Loustaud-Ratti V; Gordien E; Gozlan J; Brodard V; Chevaliez S; Calès P; Lunel-Fabiani F
    J Gastroenterol Hepatol; 2016 Oct; 31(10):1750-1756. PubMed ID: 26992056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of hepatitis B virus isolated from Black South African cancer patients, with and without hepatocellular carcinoma.
    Mak D; Kramvis A
    Arch Virol; 2020 Aug; 165(8):1815-1825. PubMed ID: 32504396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China.
    Li GJ; Harrison TJ; Yang JY; Chen QY; Wang XY; Fang ZL
    Liver Int; 2013 Jul; 33(6):936-43. PubMed ID: 23517325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.
    Tong MJ; Blatt LM; Kao JH; Cheng JT; Corey WG
    Liver Int; 2007 Dec; 27(10):1356-63. PubMed ID: 17900245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: characterization and impact on liver disease progression to hepatocellular carcinoma.
    Datta S; Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Roy G; Das S; Das K; Gupta S; Basu K; Basu A; Datta S; Chowdhury A; Banerjee S
    PLoS One; 2014; 9(10):e110012. PubMed ID: 25333524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
    Park YM; Jang JW; Yoo SH; Kim SH; Oh IM; Park SJ; Jang YS; Lee SJ
    J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between metastasis or recurrence of hepatocellular carcinoma and hepatitis B virus DNA or double mutation at 1762/1764 in the basic core promoter].
    Tan YW; Zhang YH; Jiang WJ; Xing MY; Man XB; Mao JZ; Ge GH; Wu CS; Zhu MQ; Xu J; Sun L; Zhou XP
    Zhonghua Gan Zang Bing Za Zhi; 2013 Sep; 21(9):679-83. PubMed ID: 24160343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different pre-S deletion patterns and their association with hepatitis B virus genotypes.
    Chen BF
    World J Gastroenterol; 2016 Sep; 22(35):8041-9. PubMed ID: 27672298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
    Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
    Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-core/basal-core promoter and reverse transcriptase mutations in chronic HBV infected-patients.
    Xu L; Chen EQ; Lei J; Liu L; Zhou TY; Gao Z; Tang H
    Hepatogastroenterology; 2012; 59(113):212-5. PubMed ID: 22251541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.